In a report released today, Marc Wiesenberger from B.Riley FBR initiated coverage with a Buy rating on MTBC (MTBC – Research Report) and a price target of $6.25. The company’s shares closed last Monday at $4.07.
According to TipRanks.com, Wiesenberger is ranked #605 out of 5717 analysts.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for MTBC with a $6.13 average price target.
The company has a one-year high of $5.50 and a one-year low of $3.25. Currently, MTBC has an average volume of 34.91K.
Based on the recent corporate insider activity of 65 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MTBC in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
MTBC, Inc. is a healthcare information technology company, which engages in the provision of web-based solutions and business services to healthcare providers. It operates through the Healthcare Information Technology (IT) and Practice Management segments. The Healthcare IT segment includes revenue cycle management and other services.